Then again. True laissez fair would mean no patents. So I think its fair to assume that it would be radically different in which actors are involved and in which constellations they collaborate. In such a system I wonder if &quot;drug makers&quot; would be able to charge much more than the production cost. Is first mover enough to cover RnD? I suspect not in which case &quot;drug makers&quot; would probably not be &quot;drug inventors&quot;